Buy Cilostazol online
Cilostazol 50 contains 50 mg Cilostazol.
Cilostazol 100 contains 100 mg Cilostazol.
Cilostazol without a prescription
Cilostazol is prescribed in the treatment of patients who are suffering from intermittent claudication
Cilostazol is prescribed for the reduction of symptoms of intermittent claudication, as prescribed by an increased walking distance.
Patients who are suffering from overdose with Cilostazol are likely to:
- Uneven or fast heartbeat;
- Severe headache;
- Experience diarrhea;
Cilostazol Side Effects
Cilostazol's side effects include:
- Breath shortness;
- Chest pain;
- Flu-like symptoms fever body aches chills;
- Joint pain;
- Leg cramps;
- Painful urination or bloody urine;
- Pounding or fast pulse;
- Severe headache;
- Swelling of your feet and / or ankles;
Cilostazol Drug Interactions
During your treatment with Cilostazol you should avoid taking any of these medicines:
- Sertraline (Zoloft);
- Omeprazole (Zegerid Prilosec);
- Nefazodone (Serzone);
- Ketoconazole (Nizoral);
- Itraconazole (Sporanox);
- Fluvoxamine (Luvox);
- Fluoxetine (Prozac);
- Fluconazole (Diflucan);
- Esomeprazole (Nexium);
- Diltiazem (Tiazac Cardizem);
- Clopidogrel (Plavix);
- Clarithromycin (Biaxin);
Discontinuation of therapy
The available data suggest that the dosage of Cilostazol can be reduced or discontinued without rebound (i.e. platelet hyperaggregability).
The recommended dosage of Cilostazol is 100 mg b.i.d. taken at least half an hour before or two hours after breakfast and dinner.
A dose of 50 mg b.i.d. should be considered during coadministration of such inhibitors of CYP3A4 as ketoconazole, itraconazole, erythromycin and diltiazem, and during coadministration of such inhibitors of CYP2C19 as omeprazole.
Patients may respond as early as 2 to 4 weeks after the initiation of therapy, but treatment for up to 12 weeks may be needed
before a beneficial effect is experienced.
Cilostazol is contraindicated in patients with congestive heart failure of any severity.
Cilostazol is contraindicated in patients with known or suspected hypersensitivity to the drug.
Cilostazol is contraindicated in patients with haemostatic disorders or active pathologic bleeding such as bleeding peptic ulcer and intracranial bleeding. Cilostazol inhibits platelet aggregation in a reversible manner.